Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Alnylam Pharmaceuticals (ALNY) Q2 2023 Earnings
ALNY
4
May
Confirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
-2.69
-2.26
-1.83
-1.4
Details
Expected EPS
-1.79
Actual EPS
-1.4
Surprise EPS
0.39
Surprise Percent
+21.79%
Description
Alnylam Pharmaceuticals (ALNY) has reported earnings of -1.4 per share for Q2 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login